European Journal of Preventive Cardiology and secondary cardiovascular prevention and sport cardiology. It publishes 18 issues yearly and abstracted and indexed in Scopus and the Social Sciences Citation Index. According to the "Journal Citation Reports", its 2016 impact factor is 3.6, ranking it 43th out of 125 journals in the category "Cardiac & Cardiovascular Systems". Areas of interests are Cardiovascular primary and secondary preventions, (including arterial hypertension, dyslipidaemia, diabetes, obesity, smoking cessation, healthy life style promotion), epidemiology, cardiac rehabilitation, exercise training and physiology, sport cardiology, population science intervention. European Journal of Preventive Cardiology The European Journal of Preventive Cardiology is a peer-reviewed medical journal that
Cardiovascular disease modest benefit in those at low risk of heart disease as the risk of serious bleeding is almost equal to the benefit with respect to cardiovascular problems. In those at very low risk it is not recommended. The United States Preventive Services Task Force recommends against use of aspirin for prevention in women less than 55 and men less than 45 years old; however, in those who are older it is recommends in some individuals. The use of vasoactive agents for people with pulmonary hypertension with left heart disease or hypoxemic lung diseases may cause harm and unnecessary expense. A